Financial Synergies Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24
Closed -$3.08K 326
2024
Q1
$3.08K Buy
+24
New +$2.86K ﹤0.01% 290
2023
Q4
Sell
-24
Closed -$2.18K 524
2023
Q3
$2.18K Buy
+24
New +$2.11K ﹤0.01% 299

Other funds holding NVO

Financial Synergies Wealth Advisors's NVO Position: Q2 2024 in Review

Financial Synergies Wealth Advisors sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 24 shares — an estimated $3.08K sold.

Financial Synergies Wealth Advisors first reported a position in NVO in Q3 2023 and held it in 2 quarters. The position peaked at $3.08K in Q1 2024. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Financial Synergies Wealth Advisors reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Financial Synergies Wealth Advisors sold 24 Novo Nordisk shares in Q2 2024, an estimated $3.08K.
  • Financial Synergies Wealth Advisors first reported a position in Novo Nordisk in Q3 2023 and held it in 2 quarters.
  • Financial Synergies Wealth Advisors's Novo Nordisk position peaked at $3.08K in Q1 2024.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Financial Synergies Wealth Advisors's 13F filing for Q2 2024, filed 23 Jul 2024.